CompletedPhase 3NCT00005823
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Leukemia Research Fund
- Principal Investigator
- Alan K. Burnett, MD, FRCPUniversity Hospital of Wales
- Intervention
- cytarabine(drug)
- Enrollment
- 2000 enrolled
- Eligibility
- 60 years · All sexes
- Timeline
- 1998 – 2007
Study locations (3)
- Queen Elizabeth Hospital at University of Birmingham, Birmingham, England, United Kingdom
- University College Hospital, London, England, United Kingdom
- University Hospital of Wales, Cardiff, Wales, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00005823 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.